Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial.
McHugh D, Dallos M, Teo MY, McBride SM, Gopalan A, Arfe A, Gaffney CD, Amjed M, McCann PJ, Benoliel H, Autio KA, Goh AC, DeRudder K, Ryan CJ, Szmulewitz RZ, Morgans AK, Bubley GJ, Gupta S, Klein EA, Nguyen PL, Kibel AS, Wagner AA, Kaplan ID, Eggener S, Einstein DJ, Acosta AM, Tendulkar R, VanderWeele DJ, Catalona W, Sachdev S, Liauw SL, Eastham JA, Taplin ME, Scher HI.
McHugh D, et al. Among authors: mccann pj.
Clin Cancer Res. 2026 Feb 4;32(3):479-488. doi: 10.1158/1078-0432.CCR-25-2679.
Clin Cancer Res. 2026.
PMID: 41263694
Free PMC article.
Clinical Trial.